Clinical Trial: ECOG-ACRIN EA2182

ECOG-ACRIN EA2182

Status: Closed

A Randomized Phase II Study of De-Intensified ChemoRadiation for Early-Stage Anal Squamous Cell Carcinoma (DECREASE)

EA2182 is closed to accrual, effective October 30, 2024 at 5pm EST.  Patients consented after 5pm on October 23, 2024 will not be enrolled.